Clinical Trials Browser

Phase 1 × Previously Treated CD20+ B-cell Malignancies × ocaratuzumab × Clear all

NCT01858181 2014-03-03

Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies

Phase 1 Unknown

Previously Treated CD20+ B-cell Malignancies